Skip to main content

Latest Neurology (clinical) research

The 10 most useful neurology (clinical) studies published this week, chosen from Q1 journals and graded on the Oxford CEBM evidence hierarchy. Each paper links to a short summary and the original on PubMed. Updated 22 September 2026.

Top 10 this week

Week of 20 September 2026

  1. 1

    Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis

    Neurology · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 16 September 2026

    FXIa inhibitors reduce recurrent stroke without added bleeding

  2. 2

    Intravenous alteplase compared with standard medical treatment for stroke aged over 70 years: a secondary analysis of the HOPE randomised clinical trial

    Stroke and vascular neurology · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026

    Alteplase efficacy >70 y

  3. 3

    Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysis

    Multiple sclerosis and related disorders · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 9 September 2026

    AHSCT vs alemtuzumab comparative effectiveness meta-analysis

  4. 4

    Balloon guide catheter outcomes by occlusion site in the randomized PROTECT-MT trial

    Journal of neurointerventional surgery · Q1 journal · RCT · Evidence level 1 (High) · 18 September 2026

    Balloon guide catheter effect by occlusion site in PROTECT-MT RCT

  5. 5

    Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3

    Movement disorders : official journal of the Movement Disorder Society · Q1 journal · RCT · Evidence level 1 (High) · 15 September 2026

    DL‑3‑n‑butylphthalide efficacy and safety in spinocerebellar ataxia type 3

  6. 6

    Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies: A Randomized Clinical Trial

    JAMA neurology · Q1 journal · RCT · Evidence level 1 (High) · 14 September 2026

    IVIG add‑on improves outcomes in newly diagnosed IIMs

  7. 7

    High-frequency rTMS over supplementary motor or primary motor cortex on reach-to-grasp in Parkinson's disease: A randomised controlled trial

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · Q1 journal · RCT · Evidence level 1 (High) · 11 September 2026

    Randomised trial of HF‑rTMS in Parkinson's

  8. 8

    Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive Outcomes: The CREST-H Substudy of the CREST-2 Randomized Clinical Trial

    JAMA · Q1 journal · RCT · Evidence level 1 (High) · 16 September 2026

    Asymptomatic carotid stenosis revascularisation – vascular surgery

  9. 9

    Colchicine in Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Trials

    Journal of clinical medicine · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 24 August 2026

    Colchicine meta‑analysis for secondary prevention after acute ischemic stroke

  10. 10

    Minocycline for neuroprotection in stroke and cerebral ischemia: a systematic review and meta-analysis

    Neuroradiology · Q1 journal · SR/MA of RCTs · Evidence level 1 (High) · 16 September 2026

    Systematic review, meta‑analysis of RCTs on minocycline in acute stroke

Paper of the day, last two weeks

Evidence summaries in Neurology (clinical)

Get this list every morning

The Web of Medicine app builds this feed for your specialty daily, with filters by evidence level and journal, audio summaries and Ask AI. Free on iOS and Android.

For healthcare professionals. Summaries are generated by AI from the published abstract and are not medical advice. Read the original paper before changing practice.